Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 239 participants.
Also called NCT02288273
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 239 participants
- Sponsor
- Registry
-
NCT02288273
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02288273. Randomized; triple masking; primary purpose treatment. Start 2014-12 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2017-01-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Bydureon
- Intervention (Drug)
- Placebo
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct02288273- Content hash
5881214099a15f47eff026b16374a778e67c444056c9a79a06acc5e2fd39d33a